Delivery Order SPE2DR25D1053-SPE2DR26FT672
Award Date 11/6/25
Potential Completion Date 11/7/25
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, valued at $56,123.17. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by October 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid...
- The Defense Logistics Agency awarded a delivery order valued at $1,551.91 to AmerisourceBergen Drug Corp for Teriparatide 560 MCG/2.24 ML pen injections, with completion targeted for November 10, 2025. This non-competitive, firm fixed-price delivery order was issued on November 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis. This...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 6, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, valued at $13,541.58. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. The delivery order carries no set-aside designation and represents a routine...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,702.70 for Teriparatide 560mcg/2.24ml pen on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis, particularly for...
- The Defense Logistics Agency awarded a $19,119.61 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed price contract was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Teriparatide is a synthetic parathyroid hormone medication primarily used to treat osteoporosis in patients at...
- The Defense Logistics Agency awarded a $3,468.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, with a contract ceiling value of $3,207.64 and a completion date of October 29, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,172.66 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on October 28, 2025, with completion scheduled for October 29, 2025. The award utilized firm fixed price pricing with no set-aside designation, indicating the contract was competitively awarded. Performance will be executed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $3,475.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded on September 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a synthetic form of parathyroid hormone used to treat osteoporosis and promote bone formation,...
- The Defense Logistics Agency awarded a $26,852.75 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used in...